Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1149878

registered interest
date	16/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medicine: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions officials in her Department have had with patient groups on the right of referral to research that NHS England committed to in The Implementation Framework: support offer published in June 2019.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	1013
answer	answer is ministerial correction date of answer 24/10/2019 answer text <p>The right for patients to be referred to research was announced in the NHS Long Term Plan, the concept was developed during discussions with a range of stakeholders including charities. NHS England and NHS Improvement is at an early stage in developing the detailed proposal and patient and public involvement will be an integral part of this process.</p><p> </p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 24/10/2019 11:49:31 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4056 label Biography information for Nic Dakin

1149879

registered interest
date	16/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what his policy is on compassionate use programmes that allow the use of an unauthorised medicine.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	1014
answer	answer is ministerial correction date of answer 25/10/2019 answer text <p>In the United Kingdom, there are currently arrangements in place for unlicensed medicines to be provided that are either manufactured in the UK or imported into the UK under a notification scheme. The national provisions are set out in the Human Medicines Regulations 2012 (Statutory Instrument 2012/1916). Sponsor companies may set up compassionate use programmes under the direction of a prescribing physician for specific patients.</p><p>Where an unmet need has been identified, the Early Access to Medicines Scheme run by the Medicines and Healthcare products Regulatory Agency also provides opportunity for supply of medicines awaiting a licence. These are to be prescribed under the responsibility of the treating physician, supported by a published scientific opinion that has been considered by the Commission on Human Medicines.</p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 25/10/2019 13:03:48 answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	4056 label Biography information for Nic Dakin

1149880

registered interest
date	16/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Loneliness: Social Prescribing
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to page 25 of the Government's strategy for tackling loneliness, published in October 2018, what assessment his Department has made of trends in the level of social prescribing since that strategy was published; and if he will make a statement.
tabling member constituency	Lewisham, Deptford
tabling member printed	Vicky Foxcroft
uin	1070
answer	answer is ministerial correction date of answer 25/10/2019 answer text <p>No assessment has been made.</p><p> </p><p>In the NHS Long Term Plan, NHS England and NHS Improvement committed to deliver at least £4.5 billion of new investment in primary medical and community health services over the next five years. Part of this investment will support the recruitment of over 1,000 trained social prescribing link workers in place by the end of 2020/21, rising further by 2023/24, with the aim that over 900,000 people are able to be referred to social prescribing schemes by then.</p><p> </p><p>NHS England and NHS Improvement are working to get all social prescribing services, local commissioners and providers involved in measuring the impact of social prescribing locally. It has developed a Common Outcomes Framework (COF) for social prescribing which will enable social prescribing connector schemes across the country to capture core impact data. This will help to create a consistent evidence base; support the business case; and, build a national picture of the impact of social prescribing. The outcomes cover three key areas: the impact on the person; the impact on community groups; and the impact on the health and care system. NHS England and NHS Improvement will be working with stakeholders in a phased approach over the next two years to embed the use of the measures in the COF for the evaluation of social prescribing schemes.</p><p>The COF can be found via the following link:</p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2019/01/social-prescribing-community-based-support-summary-guide.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2019/01/social-prescribing-community-based-support-summary-guide.pdf</a> <br></p><p>On 23 October 2019, the Government launched a new independent organisation: the National Academy for Social Prescribing, which is set to receive £5 million in grant funding from April next year to support its work. Since its development was announced in November 2018, the Department and NHS England have been working with a broad range of partners both in and out of Government to build consensus on the form and focus of the organisation in order that it deliver the greatest impact. The Academy will be working to: build and promote the evidence base for social prescribing and sharing best practice; developing training and accreditation across sectors; exploring new models and sources of funding; and, helping to broker relationships between sectors.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 25/10/2019 12:52:44 answering member 4380 label Biography information for Jo Churchill
tabling member	4491 label Biography information for Vicky Foxcroft

1149891

registered interest
date	16/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Surgery: Standards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps NHS England will take to record patient experience at trusts participating in the field test programme for the elective care standards proposed in the interim review of clinically-led access standards.
tabling member constituency	East Ham
tabling member printed	Stephen Timms
uin	845
answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>From early August, 12 hospital trusts began testing the use of an average (mean) wait between being referred by a general practitioner and starting treatment for routine conditions. The testing will help the National Health Service to see whether keeping the focus on patients at all stages of their pathway can help to reduce long waits. As well as using the data from trial sites to assess whether the testing has met these criteria, there will be an evaluation of the testing which will consider the impact they have had in the following areas:</p><p>- Patient safety;</p><p>- Waiting times;</p><p>- Process change;</p><p>- Patient and public experience;</p><p>- Clinical outcomes;</p><p>- Variation in outcomes, experience and performance; and</p><p>- Staff experience.</p><p> </p><p>As set out in the CRS interim report published in March, the NHS will hold a public consultation on the proposals. This will be informed by further evidence from field testing.</p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 846 question first answered 21/10/2019 12:50:42 answering member 4362 label Biography information for Edward Argar
tabling member	163 label Biography information for Sir Stephen Timms

1149892

registered interest
date	16/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Surgery: Standards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether NHS England will consult patients on changes to waiting time standards arising from the field test programme for the elective care standards proposed in the interim review of clinically-led access standards.
tabling member constituency	East Ham
tabling member printed	Stephen Timms
uin	846
answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>From early August, 12 hospital trusts began testing the use of an average (mean) wait between being referred by a general practitioner and starting treatment for routine conditions. The testing will help the National Health Service to see whether keeping the focus on patients at all stages of their pathway can help to reduce long waits. As well as using the data from trial sites to assess whether the testing has met these criteria, there will be an evaluation of the testing which will consider the impact they have had in the following areas:</p><p>- Patient safety;</p><p>- Waiting times;</p><p>- Process change;</p><p>- Patient and public experience;</p><p>- Clinical outcomes;</p><p>- Variation in outcomes, experience and performance; and</p><p>- Staff experience.</p><p> </p><p>As set out in the CRS interim report published in March, the NHS will hold a public consultation on the proposals. This will be informed by further evidence from field testing.</p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 845 question first answered 21/10/2019 12:50:42 answering member 4362 label Biography information for Edward Argar
tabling member	163 label Biography information for Sir Stephen Timms

1149902

registered interest
date	16/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent steps he has taken to ensure the adequacy of the provision of essential medicines in the event that the UK leaves the EU on 31 October 20109.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	1028
answer	answer is ministerial correction date of answer 24/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, once we have left the EU.</p><p>The Department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 24/10/2019 14:19:18 answering member 4362 label Biography information for Edward Argar
tabling member	4131 label Biography information for Jim Shannon

1149935

registered interest
date	16/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Essential Tremor: Magnetic Resonance Imagers
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what plans they have for the funding of MRI treatment of essential tremor following the recommendation by NICE for its use.
tabling member printed	Baroness Golding
uin	HL146
answer	answer is ministerial correction date of answer 25/10/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) published interventional procedure (IP) guidance on the use of Magnetic Resonance Imaging (MRI)-guided focused ultrasound as a treatment for essential tremor in June 2018. A copy of <em>Unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor</em> is attached.</p><p>NICE concluded that the evidence on the safety of unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor raises no major safety concerns. However, current evidence on its efficacy is limited in quantity. Therefore, this procedure should not be used unless there are special arrangements for clinical governance, consent, and audit or research.</p><p>IP guidance looks at procedures used for diagnosis or treatment. It considers if they are safe and work well enough for wider use in the National Health Service. Whilst compliance with IP guidance is not mandatory, it is considered best clinical practice for the NHS to take it into account.</p> answering member printed Baroness Blackwood of North Oxford question first answered 25/10/2019 10:19:11 answering member 4019 label Biography information for Baroness Blackwood of North Oxford attachment 1 file name MRI-essential-tremor.pdf title MRI-essential-tremor
tabling member	281 label Biography information for Baroness Golding

1149972

registered interest
date	16/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase uptake of the flu vaccine by social care staff.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	844
answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>Flu vaccination is recommended for all frontline social care workers. This should be provided by their employer as part of the organisation’s policy for the prevention of the transmission of flu to help protect both staff and those that they care for. To help increase uptake rates for social care workers, NHS England and NHS Improvement have a scheme to complement employers responsibilities so that vaccination is also available for social care and hospice staff from their general practitioner or community pharmacy.</p><p> </p><p>For this coming winter, Public Heath England have developed brand new resources to encourage social care worker vaccination. These resources are available at the following link:</p><p> </p><p><a href="https://campaignresources.phe.gov.uk/resources/campaigns/92-health-and-social-care-workers-flu-immunisation-/overview" target="_blank">https://campaignresources.phe.gov.uk/resources/campaigns/92-health-and-social-care-workers-flu-immunisation-/overview</a></p><p> </p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 21/10/2019 14:18:51 answering member 4362 label Biography information for Edward Argar
tabling member	151 label Biography information for Tom Brake

1149981

registered interest
date	16/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hip Replacements
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when the new minimally invasive hip replacement operation will be available on the NHS.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	1034
answer	answer is ministerial correction date of answer 24/10/2019 answer text <p>The National Institute for Health and Care Excellence has confirmed that minimally invasive hip replacement can be offered routinely as a treatment option for people with severe hip pain provided that doctors are sure that the patient understands what is involved and agrees to the treatment, and the results of the procedure are monitored. Their full guidance is here:</p><p><a href="https://www.nice.org.uk/guidance/ipg363/resources/minimally-invasive-total-hip-replacement-pdf-315958285" target="_blank">https://www.nice.org.uk/guidance/ipg363/resources/minimally-invasive-total-hip-replacement-pdf-315958285</a></p><p>It is for local clinical commissioning groups (CCGs) to decide what services they commission for the people they are responsible for – this will mean making clinical judgements about the effectiveness and value of treatments, and the best allocation of resources. CCGs do this based on the healthcare needs of their local populations and clinical evidence, to ensure they are providing the best possible, more sustainable care for their patients.</p><p> </p><p>Treatment decisions should always be made by doctors based on a patient’s individual clinical needs and informed by the NICE guidelines.</p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 24/10/2019 16:12:04 answering member 4380 label Biography information for Jo Churchill
tabling member	4131 label Biography information for Jim Shannon

1149985

registered interest
date	16/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Addictions: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what programmes are in place to support people with addictions.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	1036
answer	answer is ministerial correction date of answer 25/10/2019 answer text <p>The Government takes the issues of addiction seriously and recognises the harms they can cause to an individual and those around them. Anyone concerned about an addiction should initially approach their general practitioner for advice. Local authorities are responsible for assessing the needs of their local population and commissioning services to meet these needs, including commissioning services to support people to recover from alcohol and drug dependence. We are supporting them in this through the provision of data, guidance and targeted support and funding via the Public Health Grant. The public health grant will increase in real terms in 2020/21. This means local authorities can continue to invest in prevention and essential frontline health services.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 25/10/2019 12:53:48 answering member 4380 label Biography information for Jo Churchill
tabling member	4131 label Biography information for Jim Shannon